Molecular pathways mediating differential responses to lipopolysaccharide between human and baboon arterial endothelial cells

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 2, 2010, Pages 178-184

  Shi, Qiang ^a,b   Cox, Laura A ^a,b   Glenn, Jeremy ^a   Tejero, Maria E ^a   Hondara, Vida ^a   Vandeberg, John L ^a,b   Wang, Xing Li ^b,c  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Baboons; Endothelial cells; Inflammatory reactions; Lipopolysaccharide; Toll like receptor 4

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; SYNAPSIN I; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

ANIMALS; ATHEROSCLEROSIS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; PAPIO; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 75649110039     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05260.x     Document Type: Article

References (13)

1. Shi Q, Vandeberg JF, Jett C et al. Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet. Am. J. ClNutr. 2005 82 : 751 759.
2. Shi Q, Aida K, Vandeberg JL, Wang XL. Passage-dependent changes in baboon endothelial cells: Relevance to in vitro aging. DNA Cell Biol. 2004 23 : 502 509.
3. Redl H, Bahrami S, Schlag G, Traber DL. Clinical detection of LPS and animal models of endotoxemia. Immunobiology 1993 187 : 330 345.
4. Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 2006 86 : 9 22.
5. Huang B, Chen H, Fan M. Inhibition of TLR4 signaling pathway: Molecular treatment strategy of periodontitis-associated atherosclerosis. Med. Hypotheses 2008 70 : 614 617.
6. Lin MI, Sessa WC. Vascular endothelial growth factor signaling to endothelial nitric oxide synthase: More than a FLeeTing moment. Circ. Res. 2006 99 : 666 668.
7. Stoll LL, Denning GM, Weintraub NL. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2004 24 : 2227 2236.
8. Stoll LL, Denning GM, Li WG et al. Regulation of endotoxin-induced proinflammatory activation in human coronary artery cells: Expression of functional membrane-bound CD14 by human coronary artery smooth muscle cells. J. Immunol. 2004 173 : 1336 1343.
9. Suliman HB, Welty-Wolf KE, Carraway MS, Schwartz DA, Hollingsworth JW, Piantadosi CA. Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated E. coli. FASEB J. 2005 19 : 1531 1533.
10. Fitzgerald KA, Chen ZJ. Sorting out Toll signals. Cell 2006 125 : 834 836.
11. Li H, Sun B. Toll-like receptor 4 in atherosclerosis. J. Cell Mol. Med. 2007 11 : 88 95.
12. Shi Q, Wang J, Wang XL, Vandeberg JL. Comparative analysis of vascular endothelial cell activation by TNF-alpha and LPS in humans and baboons. Cell Biochem. Biophys. 2004 40 : 289 304.
13. Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol. 2000 1 : RESEARCH002.